ICD-10-CM/PCS MS-DRG v40.1 Definitions Manual |
||||
Skip to content |
MDC 23 Factors influencing health status and other contacts with health services |
Aftercare |
Page 22 of 22 |
PRINCIPAL DIAGNOSIS (continued)
S0000XD S06385D S20374D S30875D S37012D S46111D S56413D S61334D S65012D S70362D S83191D S91106D S99012K T2113XD T23611D T360X5D T41296D T460X4D T50B96S T63333D T81591D T85738D
T85738D | Infection and inflammatory reaction due to other nervous system device, implant or graft, subsequent encounter |
T8579XD | Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts, subsequent encounter |
T85810D | Embolism due to nervous system prosthetic devices, implants and grafts, subsequent encounter |
T85818D | Embolism due to other internal prosthetic devices, implants and grafts, subsequent encounter |
T85820D | Fibrosis due to nervous system prosthetic devices, implants and grafts, subsequent encounter |
T85828D | Fibrosis due to other internal prosthetic devices, implants and grafts, subsequent encounter |
T85830D | Hemorrhage due to nervous system prosthetic devices, implants and grafts, subsequent encounter |
T85838D | Hemorrhage due to other internal prosthetic devices, implants and grafts, subsequent encounter |
T85840D | Pain due to nervous system prosthetic devices, implants and grafts, subsequent encounter |
T85848D | Pain due to other internal prosthetic devices, implants and grafts, subsequent encounter |
T85850D | Stenosis due to nervous system prosthetic devices, implants and grafts, subsequent encounter |
T85858D | Stenosis due to other internal prosthetic devices, implants and grafts, subsequent encounter |
T85860D | Thrombosis due to nervous system prosthetic devices, implants and grafts, subsequent encounter |
T85868D | Thrombosis due to other internal prosthetic devices, implants and grafts, subsequent encounter |
T85890D | Other specified complication of nervous system prosthetic devices, implants and grafts, subsequent encounter |
T85898D | Other specified complication of other internal prosthetic devices, implants and grafts, subsequent encounter |
T859XXD | Unspecified complication of internal prosthetic device, implant and graft, subsequent encounter |
T880XXD | Infection following immunization, subsequent encounter |
T881XXD | Other complications following immunization, not elsewhere classified, subsequent encounter |
T882XXD | Shock due to anesthesia, subsequent encounter |
T883XXD | Malignant hyperthermia due to anesthesia, subsequent encounter |
T884XXD | Failed or difficult intubation, subsequent encounter |
T8851XD | Hypothermia following anesthesia, subsequent encounter |
T8852XD | Failed moderate sedation during procedure, subsequent encounter |
T8853XD | Unintended awareness under general anesthesia during procedure, subsequent encounter |
T8859XD | Other complications of anesthesia, subsequent encounter |
T886XXD | Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, subsequent encounter |
T887XXD | Unspecified adverse effect of drug or medicament, subsequent encounter |
T888XXD | Other specified complications of surgical and medical care, not elsewhere classified, subsequent encounter |
T889XXD | Complication of surgical and medical care, unspecified, subsequent encounter |
Z451 | Encounter for adjustment and management of infusion pump |
Z452 | Encounter for adjustment and management of vascular access device |
Z4682 | Encounter for fitting and adjustment of non-vascular catheter |
Z4803 | Encounter for change or removal of drains |
Z481 | Encounter for planned postprocedural wound closure |
Z4821 | Encounter for aftercare following heart transplant |
Z4822 | Encounter for aftercare following kidney transplant |
Z4823 | Encounter for aftercare following liver transplant |
Z4824 | Encounter for aftercare following lung transplant |
Z48280 | Encounter for aftercare following heart-lung transplant |
Z48288 | Encounter for aftercare following multiple organ transplant |
Z48290 | Encounter for aftercare following bone marrow transplant |
Z48298 | Encounter for aftercare following other organ transplant |
Z483 | Aftercare following surgery for neoplasm |
Z48810 | Encounter for surgical aftercare following surgery on the sense organs |
Z48811 | Encounter for surgical aftercare following surgery on the nervous system |
Z48812 | Encounter for surgical aftercare following surgery on the circulatory system |
Z48813 | Encounter for surgical aftercare following surgery on the respiratory system |
Z48814 | Encounter for surgical aftercare following surgery on the teeth or oral cavity |
Z48815 | Encounter for surgical aftercare following surgery on the digestive system |
Z48816 | Encounter for surgical aftercare following surgery on the genitourinary system |
Z48817 | Encounter for surgical aftercare following surgery on the skin and subcutaneous tissue |
Z4889 | Encounter for other specified surgical aftercare |
Z5181 | Encounter for therapeutic drug level monitoring |
Z5189 | Encounter for other specified aftercare |
Z7901 | Long term (current) use of anticoagulants |
Z7902 | Long term (current) use of antithrombotics/antiplatelets |
Z791 | Long term (current) use of non-steroidal anti-inflammatories (NSAID) |
Z792 | Long term (current) use of antibiotics |
Z793 | Long term (current) use of hormonal contraceptives |
Z794 | Long term (current) use of insulin |
Z7951 | Long term (current) use of inhaled steroids |
Z7952 | Long term (current) use of systemic steroids |
Z7960 | Long term (current) use of unspecified immunomodulators and immunosuppressants |
Z7961 | Long term (current) use of immunomodulator |
Z79620 | Long term (current) use of immunosuppressive biologic |
Z79621 | Long term (current) use of calcineurin inhibitor |
Z79622 | Long term (current) use of Janus kinase inhibitor |
Z79623 | Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor |
Z79624 | Long term (current) use of inhibitors of nucleotide synthesis |
Z79630 | Long term (current) use of alkylating agent |
Z79631 | Long term (current) use of antimetabolite agent |
Z79632 | Long term (current) use of antitumor antibiotic |
Z79633 | Long term (current) use of mitotic inhibitor |
Z79634 | Long term (current) use of topoisomerase inhibitor |
Z7964 | Long term (current) use of myelosuppressive agent |
Z7969 | Long term (current) use of other immunomodulators and immunosuppressants |
Z7982 | Long term (current) use of aspirin |
Z7983 | Long term (current) use of bisphosphonates |
Z7984 | Long term (current) use of oral hypoglycemic drugs |
Z7985 | Long-term (current) use of injectable non-insulin antidiabetic drugs |
Z79891 | Long term (current) use of opiate analgesic |
Z79899 | Other long term (current) drug therapy |
Z9221 | Personal history of antineoplastic chemotherapy |
Z9222 | Personal history of monoclonal drug therapy |
Z9223 | Personal history of estrogen therapy |
Z92240 | Personal history of inhaled steroid therapy |
Z92241 | Personal history of systemic steroid therapy |
Z9225 | Personal history of immunosuppression therapy |
Z9229 | Personal history of other drug therapy |
Centers for Medicare & Medicaid Services, 7500 Security Boulevard Baltimore, MD 21244 18 Jan 2023 08:46:59 CMS, code-revision=337, description-revision=1351 |